Evercore ISI Says Gilead Sciences (GILD) Tenofovir Risk 'waning'

Go back to Evercore ISI Says Gilead Sciences (GILD) Tenofovir Risk 'waning'

Gilead Sciences (GILD) PT Raised to $111 at Piper Sandler

January 19, 2023 6:25 AM EST

Piper Sandler analyst Do Kim raised the price target on Gilead Sciences (NASDAQ: GILD) to $111.00 (from $104.00) while maintaining a Overweight rating.... More

Gilead Sciences (GILD) PT Raised to $84 at Barclays

January 18, 2023 5:55 AM EST

Barclays analyst Carter Gould raised the price target on Gilead Sciences (NASDAQ: GILD) to $84.00 (from $76.00) while maintaining a Equalweight rating.... More